SynthesisEuropean journal of clinical pharmacology2022

Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.

Akshaya Srikanth Bhagavathula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.